Perspectives of targeted chemotherapy with delamanid in the treatment regimens of those with multiple/extensive drug resistant tuberculosis. A success, chance or uncertainty?
The article presents the review of current publications, clinical recommendations and guidelines written by foreign authors and devoted to treatment of drug resistant tuberculosis with delamanid. According to the publications, delamanid and its combinations with other anti-tuberculosis are highly ef...
Saved in:
| Main Authors: | Aleksey G. Naumov, Aleksandr V. Pavlunin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
New Terra Publishing House
2018-11-01
|
| Series: | Туберкулез и болезни лёгких |
| Subjects: | |
| Online Access: | https://www.tibl-journal.com/jour/article/view/1197 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New drugs in the treatment of drug-resistant tuberculosis in children. Experience with the use of delamanid in combination with bedaquiline
by: Ekaterina Sokolskaya, et al.
Published: (2024-12-01) -
The effect of the current chemotherapy of MDR/XDR tuberculosis on QT interval changes in ECG
by: E. M. Zhukova, et al.
Published: (2019-12-01) -
Delamanid in the Treatment of MDR/pre-XDR TB in Arkhangelsk Region in 2019–2021
by: E. S. Khimova, et al.
Published: (2023-07-01) -
Delamanid: Safety and Efficacy Analysis
by: G. N. Mozhokina, et al.
Published: (2023-12-01) -
Delamanid is a new anti-tuberculosis drug: use, limitations, and prospects
by: V. N. Zimina, et al.
Published: (2021-03-01)